Skip to main content
Log in

Renal failure caused by plasma cell infiltration in multiple myeloma

  • Case Report
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

We report on a case of severe renal failure in a 61-year-old female with multiple myeloma (MM). Two months prior to admission, the patient was diagnosed to have anemia and progressive renal failure associated with urinary Bence Jones protein and was referred to our hospital. A bone marrow biopsy revealed 40% plasma cells with κ light chain restriction. Thus, she was considered to have MM. A renal biopsy revealed neoplastic plasma cell infiltration within the kidney, moderate interstitial fibrosis, tubular atrophy, and punctate, electron-dense material along the peripheral capillary walls, tubular basement membrane, and in the interstitium of the kidney. This suggested that a combination of compression of the tubules and the microvasculature by the infiltrative process, and local light chain deposition-mediated tissue damage might be implicated in the development of renal failure in this patient. Despite a remission of bone marrow plasmacytosis with a bortezomib-based regimen, her renal function gradually deteriorated and a periodic hemodialysis program was finally required. Although the clinical impact of the direct kidney infiltration of neoplastic plasma cells on the longitudinal changes in renal function remains to be delineated, it is reasonable to consider that the infiltration of neoplastic plasma cells associated with local light chain depositions may result in irreversible renal injuries. Obviously, further studies and accumulation of additional experience with renal biopsy are required to better determine the precise and prognostic relationship between renal outcome and morphological alterations among MM patients with varying degrees of renal impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kapadia SB. Multiple myeloma: a clinicopathological study of 62 consecutively autopsied cases with multiple myeloma. Medicine. 1980;59:380–92.

    Article  CAS  PubMed  Google Scholar 

  2. Oshima K, Kanda Y, Nannya Y, Kaneko M, Hamaki T, Suguro M, et al. Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol. 2001;67:1–5.

    Article  CAS  PubMed  Google Scholar 

  3. Herrera GA, Joseph L, Gu X, Hough A, Barlogie B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004;128:875–9.

    PubMed  Google Scholar 

  4. The kidney in multiple myeloma. West J Med. 1978;129:41–8.

  5. Pasquali S, Zucchelli P, Casanova S, Cagnoli L, Confalonieri R, Pozzi C, et al. Renal histological lesions and clinical syndromes in multiple myeloma. Clin Nephrol. 1987;27:222–8.

    PubMed  CAS  Google Scholar 

  6. Lommatzsch SE, Bellizzi AM, Cathro HP, Rosner MH. Acute renal failure caused by renal infiltration by hematolymphoid malignancy. Ann Diag Pathol. 2006;10:230–4.

    Article  Google Scholar 

  7. Herrera GA, Picken MM. Renal diseases associated with plasma cell dyscrasias, amyloidosis, Waldenström macroglobulinemia, and cryoglobulinemic nephropathies. In: Jennette JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 853–910.

  8. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543–6.

    Article  CAS  PubMed  Google Scholar 

  9. Kyrtsonis MC, Maltezas D, Tzenou T, Koulieris E, Bradwell AR. Staging system and prognostic factors as a guide to therapeutic decisions in multiple myeloma. Semin Hematol. 2009;46:110–7.

    Article  PubMed  Google Scholar 

  10. Korbet SM, Schwartz MM. Multiple myeloma. J Am Soc Nephrol. 2006;17:2533–45.

    Article  PubMed  Google Scholar 

  11. Pillon L, Sweeting RS, Arora A, Notkin A, Ballard HS, Wieczorek RL, et al. Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there still a role for plasmapheresis? Kidney Int. 2008;74:956–61.

    Article  PubMed  Google Scholar 

  12. Border WA, Cohen AH. Renal biopsy diagnosis of clinically silent multiple myeloma. Ann Int Med. 1980;93:43–6.

    Article  CAS  PubMed  Google Scholar 

  13. Hill GS, Morel-Maroger L, Méry JP, Brouet JC, Mignon F. Renal lesions in multiple myeloma: their relationship to associated protein abnormalities. Am J Kidney Dis. 1983;2:423–38.

    Article  CAS  PubMed  Google Scholar 

  14. Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant. 1998;13:1438–45.

    Article  CAS  PubMed  Google Scholar 

  15. Laszik ZG, Silva FG. Hemolytic uremic syndrome, thrombotic thrombocytopenic perpura, and other thrombotic microangiopathies. In: Jennette JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 701–64.

  16. Galani Z, Viniou N, Kyrtsonis MC, Sachanas S, Antoniou T, Dimopoulou MN, et al. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission. Anticancer Res. 2007;27:571–4.

    PubMed  Google Scholar 

  17. Pozzi C, D’Amico M, Fogazzi GB, Curioni S, Ferrario F, Pasquali S, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis. 2003;42:1154–63.

    Article  PubMed  Google Scholar 

  18. Sellin L, Friedl C, Klein G, Waldherr R, Rump LC, Weiner SM. Acute renal failure due to a malignant lymphoma infiltration uncovered by renal biopsy. Nephrol Dial Transplant. 2004;19:2657–60.

    Article  PubMed  Google Scholar 

  19. Dimopoulos MA, Kastritis E, Rosinol L, Blade J, Ludwig H. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia. 2008;22:1485–93.

    Article  CAS  PubMed  Google Scholar 

  20. Blade J, Fernandez-Llama P, Bosch F, Montoliu J, Lens XM, Montoto S, et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998;158:1889–93.

    Article  CAS  PubMed  Google Scholar 

  21. Kastritis E, Anagnostopoulos A, Roussou M, Gika D, Matsouka C, Barmprousi D, et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents. Haematologica. 2007;92:546–9.

    Article  CAS  PubMed  Google Scholar 

  22. Roussou M, Kastritis E, Christoulas D, Migkou M, Gavriatopoulou M, Grapsa I, et al. Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents. Leuk Res. 2010;34:1395–7.

    Article  CAS  PubMed  Google Scholar 

  23. Morabito F, Gentile M, Ciolli S, Petrucci MT, Galimberti S, Mele G, et al. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian myeloma network GIMEMA. Eur J Haematol. 2010;84:223–8.

    Article  CAS  PubMed  Google Scholar 

  24. Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol. 2009;4:745–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Blade RTJ, Lopez-Pedret ACJ, Rozman MC, Revert L. Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases. Br J Haematol. 1995;91:854–9.

    Article  PubMed  Google Scholar 

  26. Terpos E, Politou M, Rahemtulla A. Tumor lysis sundrome in multiple myeloma after bortezomib (VELCADE) administration. J Cancer Res Clin Oncol. 2004;130:623–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsu Akimoto.

About this article

Cite this article

Hanawa, S., Akimoto, T., Uehara, E. et al. Renal failure caused by plasma cell infiltration in multiple myeloma. Clin Exp Nephrol 15, 586–590 (2011). https://doi.org/10.1007/s10157-011-0437-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-011-0437-x

Keywords

Navigation